News

Public · Published

Alphabet kicks off euro-denominated bond sale, IFR reports

Alphabet began selling euro-denominated bonds on Monday, according to IFR, in a seven-part offering with maturities ranging from two to 19 years. The bonds were expected to be priced later that day, as the company tested investor appetite after recent weakness in technology shares and bonds.

Published:

Updated:

What happened

Alphabet began selling euro-denominated bonds on Monday, according to IFR, in a seven-part offering with maturities ranging from two to 19 years. The bonds were expected to be priced later that day, as the company tested investor appetite after recent weakness in technology shares and bonds.

Confirmed

Global impact / market context

Bond sales give Alphabet a way to raise money from investors to help pay for infrastructure, including data centers. If buyers demand high returns or show limited interest, borrowing could become more costly, potentially increasing the expense of planned investment as questions about AI returns weigh on technology debt and shares.

Analyst inference

The sale comes after recent declines in technology shares and bonds amid doubts about whether AI investment will generate enough financial returns. The article says analysts had expected more European bond sales from large technology companies seeking funds for infrastructure, making investor demand for Alphabet’s offering a relevant test.

Confirmed

What to watch

  1. Watch for the reported pricing and investor demand across the seven bond tranches; these details would show the borrowing cost Alphabet accepts and buyers’ appetite for its debt. Analyst inference
  2. Track whether other large technology companies follow with European bond sales to fund infrastructure, as analysts cited in the article had anticipated a pickup in issuance. Analyst inference
  3. The article reports recent technology-sector weakness, including a 5% October fall in the Nasdaq and an almost 19% monthly decline in Alphabet’s US-listed shares. Confirmed

Evidence

  • Original source link unavailable